Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Nautilus Biotechnology Inc | NAUT | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 2.43 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.43 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 2.16 - 4.65 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 2.43 | USD |
Nautilus Biotechnology Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 307.74M | 125.10M | - | 0 | -63.68M | -0.51 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Nautilus Biotechnology News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NAUT Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.54 | 2.67 | 2.4258 | 2.50 | 64,842 | -0.11 | -4.33% |
| 1 Month | 2.72 | 3.09 | 2.4258 | 2.67 | 65,834 | -0.29 | -10.66% |
| 3 Months | 3.08 | 3.1074 | 2.38 | 2.70 | 79,455 | -0.65 | -21.10% |
| 6 Months | 2.65 | 3.4547 | 2.30 | 2.81 | 90,093 | -0.22 | -8.30% |
| 1 Year | 2.80 | 4.65 | 2.16 | 3.04 | 91,445 | -0.37 | -13.21% |
| 3 Years | 11.49 | 12.38 | 1.50 | 4.97 | 255,416 | -9.06 | -78.85% |
| 5 Years | 11.49 | 12.38 | 1.50 | 4.97 | 255,416 | -9.06 | -78.85% |
Nautilus Biotechnology Description
| With its corporate headquarters in Seattle and its research and development headquarters in the San Francisco Bay Area, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. |
